What is CG Oncology's other non-current assets?

CG Oncology (CGON) reported other non-current assets of $2.68M in Q1 2026.

How has CG Oncology's other non-current assets changed year-over-year?

CG Oncology's other non-current assets decreased by 89.4% year-over-year, from $25.18M to $2.68M.

What is the long-term trend for CG Oncology's other non-current assets?

Over 2 years (2023 to 2025), CG Oncology's other non-current assets has grown at a 839.8% compound annual growth rate (CAGR), from $19K to $1.68M.

What does other non-current assets mean?

Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

CG Oncology CGON Other Non-Current Assets

Other Non-Current Assets at other companies

Cogent Biosciences, Inc.COGT

$1.94M-60.1%

Tango TherapeuticsTNGX

$293K+29,200%

Immunovant, Inc.IMVT

$7.68M+0.8%

Summit TherapeuticsSMMT

$8.23M+98.6%

CRISPR TherapeuticsCRSP

$28.98M+39.5%

ExelixisEXEL

——

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's other non-current assets?: CG Oncology (CGON) reported other non-current assets of $2.68M in Q1 2026.
How has CG Oncology's other non-current assets changed year-over-year?: CG Oncology's other non-current assets decreased by 89.4% year-over-year, from $25.18M to $2.68M.
What is the long-term trend for CG Oncology's other non-current assets?: Over 2 years (2023 to 2025), CG Oncology's other non-current assets has grown at a 839.8% compound annual growth rate (CAGR), from $19K to $1.68M.
What does other non-current assets mean?: Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.